Suppression of human peripheral blood mononuclear cell function by methadone and morphine

P K Peterson1, G Gekker, C Brummitt

  • 1Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55415.

Insights

Opioid medications like methadone and morphine can suppress immune cell function. This study found that these drugs impair the ability of peripheral blood mononuclear cells (PBMC) to produce critical defense molecules.

Area of Science:

  • Immunology
  • Pharmacology
  • Cell Biology

Background:

  • In vitro studies show morphine impairs monocyte respiratory burst and lymphocyte interferon-gamma (IFN-gamma) production.
  • Investigating in vivo opiate effects on immune cell function is crucial.

Purpose of the Study:

  • To assess the in vivo impact of methadone on peripheral blood mononuclear cell (PBMC) functions.
  • To determine if methadone or morphine can suppress immune cell activity in healthy individuals.

Main Methods:

  • PBMC were isolated from patients on methadone maintenance therapy.
  • Superoxide anion (O2-) production and IFN-gamma release were measured in response to stimulants like phorbol myristate acetate (PMA) and concanavalin A.
  • PBMC from healthy controls were cultured with methadone or morphine.

Main Results:

  • PBMC from methadone patients showed impaired O2- generation capacity, which persisted after 48h culture.
  • IFN-gamma production by lymphocytes remained intact in methadone patients.
  • In vitro exposure of healthy control PBMC to low concentrations of methadone or morphine suppressed PMA-stimulated O2- release.

Conclusions:

  • In vivo methadone exposure impairs PBMC superoxide anion generation.
  • Opiates like methadone and morphine can directly suppress immune cell function at low concentrations.
  • Further research is needed on the clinical implications of opiate-induced immunosuppression, particularly concerning host defense against opportunistic infections.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...